DANBURY, Conn., Oct. 19, 2017 -- Effective immediately or as contract terms allow, Addivant™, a global leader in polymer additives, is increasing the price of a selected list of Polymerization Inhibitors, Stabilizers and Antioxidants by up to 20%, depending on product lines. The increase is driven by sharp raw material cost increases and global supply shortages resulting from China’s recent reinforcement of its environmental protection policies. Products affected by the increase are NAUGARD® I-5, ANOX®IC-14, LOWINOX® CPL, NAUGARD® Q and Hindered Amine Light Stabilizers.
About Addivant™
Addivant™ is an innovator in the field of polymer additives, developing customized solutions that provide customers enhanced application performance, safe handling, and reduction in cost of use. The company is recognized industry-wide for its extensive portfolio of specialty additives including antioxidants, light stabilizers, rubber additives, polymer modifiers, metal deactivators, polymerization inhibitors and intermediates. Addivant is an international company, with 11 plants in five regions as well as research, manufacturing and sales facilities around the globe. Addivant maintains its global headquarters in Connecticut, USA with regional headquarters in: Al Jubail, Saudi Arabia, Basel, Switzerland, and Shanghai, China. Addivant is an independent portfolio company of SK Capital. Visit www.addivant.com for more information.
Addivant™, NAUGARD®, ANOX® and LOWINOX® are trademarks of Addivant.
Contacts:
Beverly Kindermann
[email protected]
Tel: +1 203 702 6182


Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change 



